… were better than molnupiravir for the prevention of COVID-19-related hospitalization or …
their virological efficacy, both anti-viral agents (nirmatrelvir plus ritonavir and molnupiravir) …

… clinical trial of molnupiravir in patients with COVID-19 shows … who have mild to moderate
COVID-19 and who have at least one … to severe COVID-19, and for whom alternative COVID-19 …

… and efficacy of molnupiravir include MOVe-IN and MOVe-OUT trials conducted in hospitalized
and non-hospitalized COVID-19 … non-hospitalized adults with COVID-19. While no clinical …

… population with COVID-19 infection, reporting data on MOV efficacy in the … conducted on
MOV efficacy for COVID-19 treatment. … the efficacy of oral compounds as treatment of COVID-19. …

… Covid-19 is our epoch-defining pandemic — and it is still ongoing. Despite the development
of several effective Covid-19 … evaluating the safety and efficacy of molnupiravir, an oral drug …

… efficacy for COVID-19 treatments. Additionally, this study provides evidence of the
efficacy of molnupiravir which supplements the current ongoing clinical trials of this drug. …

… mild to moderate COVID-19 who received bamlanivimab in … with mild to moderate COVID-19
from March to November … of concern which impact efficacy of therapeutic neutralizing …

… low variability following administration to healthy volunteers at clinically relevant doses is
well positioned to be evaluated for clinical efficacy and safety in large-scale COVID-19 studies. …

… molnupiravir as an oral treatment for COVID-19 in nonhospitalized adults (MOVe-OUT) showed
good efficacy… report on the efficacy and safety of molnupiravir in advanced CKD patients. …

… benefit of molnupiravir therapy for COVID-19 patients. In the … who received molnupiravir for
the treatment of COVID-19. We … in patients with low COVID-19 vaccination coverage only [30,…